Find a topic

17 topics

01

Four principal sources

The GPO and CNF presentations are the principal sources for the project narrative and development direction. The 2024 article and Rayong abstract supply study detail. Keeping their roles distinct prevents aspirations in presentations from being retold as research findings.

Source: GPO 2026, pp. 1–24; CNF 2026, pp. 1–61; Rayong abstract, pp. 1–3; 2024 paper, pp. 123–132

SourceLength / dateWhat it explains
GPO 202624 pages / 4 February 2026Team, product, GPO plans, and field engagement
CNF 17th61 pages / 26 March 2026Service problem, workflow, technology, and Rayong results
2024 articleJournal pages 123–132Methods, dataset, and clip-test results
Rayong abstract3 pages, Thai and EnglishParticipant groups and reported results

02

Reading GPO: from the problem to the development plan

Start with page 2 for the team and pages 3–7 for access barriers and the smartphone concept. Continue to pages 8–11 to see how clinical-practice testing and medical-device preparation are presented as parallel workstreams.

Pages 12–19 connect the project to heart-failure clinic context, regional activities, and the 2026 agenda. Pages 20–23 then introduce the handheld ultrasound direction. The GPO guide distinguishes dated activities from future plans.

Source: GPO 2026, pp. 2–8, 11–23

03

Reading CNF: from concept to evaluation

Pages 4–22 explain the development rationale and service pathway. Pages 26–41 demonstrate application use and reports. Pages 42–48 discuss readiness, architecture, the model, and device-integration directions.

Page 52 records the GPO Ignite 2025 award, pages 54–59 present the Rayong study, and page 60 invites research collaboration. Reading these as separate subjects avoids treating recognition or an invitation as clinical validation.

Source: CNF 2026, pp. 4–22, 26–48, 52–60

04

A reading path for evidence reviewers

Read data selection before the headline numbers: the 2024 work uses eligible clips split into training and test sets, while Rayong has participant groups with two assessment indications. Then examine subgroup results and metric definitions before interpreting overall performance.

The evidence guide explains why 96.2% and 93.6% should not be averaged and why the Mildly Reduced EF and fair LV limitations belong alongside the overall results. It is intended for teams assessing collaboration or designing further evaluation.

Source: 2024 paper, pp. 127–132; Rayong abstract, pp. 1–3; CNF 2026, pp. 55–59

05

Page references and document status

GPO and CNF references use PDF page order; the 2024 article uses journal pagination, 123–132. Some slides consist of demonstration images or headings. The guides therefore summarize chapters without transcribing personal details from screenshots.

The published study links to its official article page. Internal presentations and the abstract are identified by name and page without full-document downloads. For discussion of methods or collaboration materials, contact LINE mae.t.ace or call 0615656599.

Source: GPO 2026, pp. 1–24; CNF 2026, pp. 1–61; 2024 paper, pp. 123–132

SOURCE NOTES

Sources for this page

  1. เอกสารนำเสนอ / Presentation: EasyEF AI Echo, GPO, 4 February 2026 — หน้า / pp. 1–24
  2. เอกสารนำเสนอ / Presentation: EasyEF Lunch Symposium, CNF 17th, 26 March 2026 — หน้า / pp. 1–61
  3. บทความวิจัยปี 2567 / 2024 original article — J Prapokklao Hosp Clin Med Educat Center 41(2):123–132 ↗
  4. บทคัดย่อการศึกษาระยอง ไทย–อังกฤษ หน้า 1–3 / Rayong study abstract, Thai and English, pp. 1–3; publication and peer-review status not verified / ยังไม่ยืนยันสถานะตีพิมพ์และการทบทวนโดยผู้ทรงคุณวุฒิ

Presentations reflect information at the time they were prepared. Explore context and evidence status in the resource library.

Explore the source library →